Back
Verrica Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
25
VRCA
Verrica Pharmaceuticals
Last Price:
0.87
Seasonality Move:
34.27%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
65.58
Seasonality Move:
13.04%
Sell
25
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $0.84. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.66. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 34.29 | Sell |
| Chaikin Money Flow: | -243328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.99 - 1.61) | Sell |
| Bollinger Bands (100): | (1.02 - 6.26) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.6 | Sell |
| Relative Strength Index (14 RSI): | 37.31 | Sell |
| Chaikin Money Flow: | 458693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.62 - 70.38) | Sell |
| Bollinger Bands (100): | (70.1 - 87.88) | Sell |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.51 | Sell |
| 200-day SMA: | 5.17 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.19 | Sell |
| 50-day EMA: | 1.85 | Sell |
| 200-day EMA: | 4.21 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.42 | Buy |
| 20-day SMA: | 68.09 | Sell |
| 50-day SMA: | 71.64 | Sell |
| 200-day SMA: | 81.94 | Sell |
| 8-day EMA: | 66.7 | Sell |
| 20-day EMA: | 67.88 | Sell |
| 50-day EMA: | 71.83 | Sell |
| 200-day EMA: | 80.55 | Sell |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.73 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Verrica Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||